Silo Pharma, Inc. (SILO)
Total Valuation
Silo Pharma has a market cap or net worth of $5.51 million. The enterprise value is -$2.15 million.
Market Cap | 5.51M |
Enterprise Value | -2.15M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Silo Pharma has 2.84 million shares outstanding. The number of shares has increased by 34.83% in one year.
Shares Outstanding | 2.84M |
Shares Change (YoY) | +34.83% |
Shares Change (QoQ) | -6.76% |
Owned by Insiders (%) | 6.07% |
Owned by Institutions (%) | 5.65% |
Float | 2.52M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 76.45 |
Forward PS | 300.23 |
PB Ratio | 0.89 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.90, with zero debt.
Current Ratio | 9.90 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -759.05 |
Financial Efficiency
Return on equity (ROE) is -47.10% and return on invested capital (ROIC) is -62.42%.
Return on Equity (ROE) | -47.10% |
Return on Assets (ROA) | -39.00% |
Return on Capital (ROIC) | -62.42% |
Revenue Per Employee | $24,034 |
Profits Per Employee | -$1.23M |
Employee Count | 3 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.98% in the last 52 weeks. The beta is 1.32, so Silo Pharma's price volatility has been higher than the market average.
Beta (1Y) | 1.32 |
52-Week Price Change | -4.98% |
50-Day Moving Average | 1.60 |
200-Day Moving Average | 1.72 |
Relative Strength Index (RSI) | 68.14 |
Average Volume (30 Days) | 101,580 |
Short Selling Information
The latest short interest is 50,721, so 1.78% of the outstanding shares have been sold short.
Short Interest | 50,721 |
Short Previous Month | 49,428 |
Short % of Shares Out | 1.78% |
Short % of Float | 2.01% |
Short Ratio (days to cover) | 0.44 |
Income Statement
In the last 12 months, Silo Pharma had revenue of $72,102 and -$3.70 million in losses. Loss per share was -$1.20.
Revenue | 72,102 |
Gross Profit | 66,264 |
Operating Income | -3.86M |
Pretax Income | -3.70M |
Net Income | -3.70M |
EBITDA | -3.70M |
EBIT | -3.70M |
Loss Per Share | -$1.20 |
Balance Sheet
The company has $7.67 million in cash and no debt, giving a net cash position of $7.67 million or $2.70 per share.
Cash & Cash Equivalents | 7.67M |
Total Debt | n/a |
Net Cash | 7.67M |
Net Cash Per Share | $2.70 |
Equity / Book Value | 6.18M |
Book Value Per Share | 2.17 |
Working Capital | 6.91M |
Cash Flow
Operating Cash Flow | -3.22M |
Capital Expenditures | n/a |
Free Cash Flow | -3.22M |
FCF Per Share | -$1.05 |
Margins
Gross margin is 91.90%, with operating and profit margins of -5,347.41% and -5,132.57%.
Gross Margin | 91.90% |
Operating Margin | -5,347.41% |
Pretax Margin | -5,132.57% |
Profit Margin | -5,132.57% |
EBITDA Margin | -5,125.81% |
EBIT Margin | -5,125.81% |
FCF Margin | -4,472.13% |
Dividends & Yields
Silo Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -34.83% |
Shareholder Yield | -34.83% |
Earnings Yield | -67.14% |
FCF Yield | -58.50% |
Analyst Forecast
The average price target for Silo Pharma is $10.00, which is 429.10% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $10.00 |
Price Target Difference | 429.10% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 0.31% |
EPS Growth Forecast (5Y) | -5.29% |
Stock Splits
The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:50.
Last Split Date | Sep 15, 2022 |
Split Type | Reverse |
Split Ratio | 1:50 |
Scores
Silo Pharma has an Altman Z-Score of -0.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.35 |
Piotroski F-Score | 2 |